301 related articles for article (PubMed ID: 30384485)
1. A Functional Analysis of the Cyclophilin Repertoire in the Protozoan Parasite
Perrone AE; Milduberger N; Fuchs AG; Bustos PL; Bua J
Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30384485
[No Abstract] [Full Text] [Related]
2. Analysis of the Trypanosoma cruzi cyclophilin gene family and identification of Cyclosporin A binding proteins.
Potenza M; Galat A; Minning TA; Ruiz AM; Duran R; Tarleton RL; Marín M; Fichera LE; Búa J
Parasitology; 2006 Jun; 132(Pt 6):867-82. PubMed ID: 16700961
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of a cyclophilin isoform in Trypanosoma cruzi.
Búa J; Aslund L; Pereyra N; García GA; Bontempi EJ; Ruiz AM
FEMS Microbiol Lett; 2001 Jun; 200(1):43-7. PubMed ID: 11410347
[TBL] [Abstract][Full Text] [Related]
4. Cyclophilin 19 secreted in the host cell cytosol by Trypanosoma cruzi promotes ROS production required for parasite growth.
Dos Santos GP; Abukawa FM; Souza-Melo N; Alcântara LM; Bittencourt-Cunha P; Moraes CB; Jha BK; McGwire BS; Moretti NS; Schenkman S
Cell Microbiol; 2021 Apr; 23(4):e13295. PubMed ID: 33222354
[TBL] [Abstract][Full Text] [Related]
5. Modelling and study of cyclosporin A and related compounds in complexes with a Trypanosoma cruzi cyclophilin.
Carraro R; Búa J; Ruiz A; Paulino M
J Mol Graph Model; 2007 Jul; 26(1):48-61. PubMed ID: 17174582
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of Cyclophilin (TcCyP19) in Trypanosoma cruzi populations susceptible and resistant to benznidazole.
Rêgo JV; Duarte AP; Liarte DB; de Carvalho Sousa F; Barreto HM; Bua J; Romanha AJ; Rádis-Baptista G; Murta SM
Exp Parasitol; 2015 Jan; 148():73-80. PubMed ID: 25450774
[TBL] [Abstract][Full Text] [Related]
7. Anti-Trypanosoma cruzi effects of cyclosporin A derivatives: possible role of a P-glycoprotein and parasite cyclophilins.
Búa J; Fichera LE; Fuchs AG; Potenza M; Dubin M; Wenger RO; Moretti G; Scabone CM; Ruiz AM
Parasitology; 2008 Feb; 135(2):217-28. PubMed ID: 17922928
[TBL] [Abstract][Full Text] [Related]
8.
Perrone AE; Pinillo M; Rial MS; Fernández M; Milduberger N; González C; Bustos PL; Fichera LE; Laucella SA; Albareda MC; Bua J
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569250
[TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi infection in Cyclophilin D deficient mice.
Milduberger N; Bustos PL; González C; Perrone AE; Postan M; Bua J
Exp Parasitol; 2021 Jan; 220():108044. PubMed ID: 33253715
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.
Yau WL; Blisnick T; Taly JF; Helmer-Citterich M; Schiene-Fischer C; Leclercq O; Li J; Schmidt-Arras D; Morales MA; Notredame C; Romo D; Bastin P; Späth GF
PLoS Negl Trop Dis; 2010 Jun; 4(6):e729. PubMed ID: 20614016
[TBL] [Abstract][Full Text] [Related]
11. Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity.
Kulkarni MM; Karafova A; Kamysz W; Schenkman S; Pelle R; McGwire BS
J Biol Chem; 2013 Mar; 288(12):8772-8784. PubMed ID: 23386612
[TBL] [Abstract][Full Text] [Related]
12. Is It Possible to Intervene in the Capacity of
Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Menon SS; Ferreira VP; Ferreira A
Front Immunol; 2021; 12():789145. PubMed ID: 34975884
[TBL] [Abstract][Full Text] [Related]
13. In vitro anti-parasitic activity of Cyclosporin A analogs on Trypanosoma cruzi.
Búa J; Ruiz AM; Potenza M; Fichera LE
Bioorg Med Chem Lett; 2004 Sep; 14(18):4633-7. PubMed ID: 15324878
[TBL] [Abstract][Full Text] [Related]
14. Reevaluating the Trypanosoma cruzi proteomic map: The shotgun description of bloodstream trypomastigotes.
Brunoro GV; Caminha MA; Ferreira AT; Leprevost Fda V; Carvalho PC; Perales J; Valente RH; Menna-Barreto RF
J Proteomics; 2015 Feb; 115():58-65. PubMed ID: 25534883
[TBL] [Abstract][Full Text] [Related]
15. Analysis of cyclosporin A and a set of analogs as inhibitors of a T. cruzi cyclophilin by docking and molecular dynamics.
Carraro R; Iribarne F; Paulino M
J Biomol Struct Dyn; 2016; 34(2):399-413. PubMed ID: 26046477
[TBL] [Abstract][Full Text] [Related]
16. The challenge of Chagas' disease: has the human pathogen, Trypanosoma cruzi, learned how to modulate signaling events to subvert host cells?
Lima FM; Oliveira P; Mortara RA; Silveira JF; Bahia D
N Biotechnol; 2010 Dec; 27(6):837-43. PubMed ID: 20172059
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress damage in the protozoan parasite Trypanosoma cruzi is inhibited by Cyclosporin A.
Bustos PL; Perrone AE; Milduberger N; Postan M; Bua J
Parasitology; 2015 Jul; 142(8):1024-32. PubMed ID: 25823521
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive glycoprofiling of the epimastigote and trypomastigote stages of Trypanosoma cruzi.
Alves MJ; Kawahara R; Viner R; Colli W; Mattos EC; Thaysen-Andersen M; Larsen MR; Palmisano G
J Proteomics; 2017 Jan; 151():182-192. PubMed ID: 27318177
[TBL] [Abstract][Full Text] [Related]
19. Overexpression, purification and assessment of cyclosporin binding of a family of cyclophilins and cyclophilin-like proteins of the human malarial parasite Plasmodium falciparum.
Marín-Menéndez A; Bell A
Protein Expr Purif; 2011 Aug; 78(2):225-34. PubMed ID: 21549842
[TBL] [Abstract][Full Text] [Related]
20. Trypanosoma cruzi surface mucins: host-dependent coat diversity.
Buscaglia CA; Campo VA; Frasch AC; Di Noia JM
Nat Rev Microbiol; 2006 Mar; 4(3):229-36. PubMed ID: 16489349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
